C International Psychogeriatric Association 2013 International Psychogeriatrics (2014), 26:4, 627–635 doi:10.1017/S1041610213002317
Assessment of regional MR diffusion changes in dementia with Lewy bodies and Alzheimer’s disease ...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................
James O’Donovan,1 Rosie Watson,1 Sean J. Colloby,1 Andrew. M. Blamire3 and John T. O’Brien1,2 1
Institute for Ageing and Health, Campus for Ageing and Vitality, Newcastle University, Newcastle-upon-Tyne, UK Department of Psychiatry, Addenbrooke’s Hospital, University of Cambridge, Cambridge, UK 3 Newcastle Magnetic Resonance Centre and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK 2
ABSTRACT
Background: Dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD) are common forms of dementia, yet diagnosis is often difficult. Diffusion tensor imaging (DTI) is an MR technique used to assess neuronal microstructural integrity that may help develop a better understanding of the differences between the conditions. Methods: We recruited subjects with DLB (n = 35), AD (n = 36), and similar aged healthy controls (n = 35). T1 weighted anatomical and diffusion MR images were acquired at 3 Tesla. Region of interest (ROI) analysis was used to measure fractional anisotropy (FA) and mean diffusivity (MD) in five structures: precuneus, thalamus, pons, midbrain, and amygdala. Where appropriate diffusivity measures (FA, MD) were correlated with selected clinical measures. Results: Compared to controls, DLB subjects were characterized by reduced FA (p = 0.016) and increased MD (p = 0.007) in the precuneus. Amygdala diffusivity was positively correlated with UPDRS-III score in DLB (p = 0.003). In AD, reduced FA in the precuneus was also observed compared to controls (p = 0.026), and was associated with impaired global cognition (MMSE score) (p = 0.03). Conclusions: Our findings highlight the potential importance of the precuneus in the pathogenesis of DLB as well as AD. Diffusion tensor MRI may shed new light on the different neurobiological changes underpinning the key clinical features of DLB and AD. Key words: DLB, Lewy, dementia, Alzheimer’s disease, diffusion tensor imaging, MRI
Introduction The most common subtypes of dementia in later life are Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB). Distinguishing between AD and DLB during life can be difficult as symptoms between the two conditions often overlap especially in the advanced stages of the disease. The clinical diagnostic criteria for DLB also lack sensitivity so that many cases are missed or misdiagnosed (Litvan et al., 2003). Furthermore, neuroimaging changes in dementia can also overlap with those seen in normal aging (Minati et al., 2007). Structural neuroimaging, including magnetic resonance imaging (MRI), is an important part Correspondence should be addressed to: Dr. Sean Colloby, Institute for Ageing and Health, Campus for Ageing and Vitality, Newcastle University, Newcastleupon-Tyne, UK. Phone: +44-191-248-1321; Fax: +44-191-248-1301. Email: [email protected]. Received 17 Aug 2013; revision requested 15 Sep 2013; revised version received 5 Oct 2013; accepted 4 Nov 2013. First published online 16 December 2013.
of the clinical work up for all patients with dementia. More recently an advanced MRI method, diffusion tensor imaging (DTI), has emerged as a technique to assess the microstructure of the brain. It is thought that DTI may be a more sensitive neuroimaging procedure compared to conventional structural MRI, as it may detect subtle preclinical changes (Ringman et al., 2007). DTI is an advanced MRI technique that allows assessment of the tissue microstructure by measuring the incoherent motion of water molecules (Le Bihan et al., 1986). The diffusion of molecules in tissues varies depending on the interactions with obstacles such as tissue membranes and fibers (Le Bihan, 2007). White matter tracts in the brain have a fibrous internal structure, meaning that the diffusion of water along these tracts is directionally dependent; a property known as anisotropy (Mori and Zhang, 2006). Water molecules will diffuse further along a tract if aligned in the same direction, as theoretically there are “fewer obstacles to prevent movement”
628
J. O’Donovan et al.
(Mori and Zhang, 2006). There are two important measures that can be derived from DTI; Mean diffusivity (MD) and Fractional anisotropy (FA). MD represents the overall displacement of water molecules whereas FA quantifies the directionality of local tract structure. Typically DTI abnormalities are represented by increased MD and/or reduced FA. For example, an FA value of 0 would indicate that the diffusion of water molecules is the same in all directions, whereas a value of 1 would indicate diffusivity of molecules in a single direction. When there is damage to the walls of the axons, FA will decrease as the water molecules adopt a more random direction of diffusion. It is thought that when combined with the macro-structural changes on conventional MRI scanning, DTI may be used to assist with earlier diagnosis of different dementia subtypes. There have been a number of diffusion imaging studies in AD (Vasconcelos et al., 2009), the majority of which have compared AD and similar aged controls or with subjects with mild cognitive impairment. The most consistent findings are that posterior brain regions seem to be more affected than anterior regions during the early stages of AD, then, as the disease progresses, the limbic and frontal structures also become involved followed lastly by the primary sensorimotor regions, which have been shown to correlate with the clinical manifestations of the disease (Medina and Gaviria, 2008). There have been fewer studies in DLB and with varying results (Watson and O’Brien, 2012). Some studies report widespread diffusivity changes in comparison to healthy controls (Bozzali et al., 2005; Lee et al., 2010), whereas others report little to no change (Firbank et al., 2007; Kantarci et al., 2010). Most DTI studies in DLB have utilized analysis methods that focus on cortical structures and key neuronal WM tracts. The most consistent findings have been changes in the Inferior Longitudinal Fasciculus (ILF) and precuneal WM tracts, which form part of the ventral and dorsal visual streams respectively (Ota et al., 2009; Kantarci et al., 2010; Kiuchi et al., 2011; Watson et al., 2012a). These findings are particularly interesting given that visuoperceptual impairments and visual hallucinations are common in DLB (McKeith et al., 2005). A study in 2010 by Kantarci et al., revealed increased diffusivity in the amygdala in DLB compared to controls (Kantarci et al., 2010), which also correlated with the UPDRS-III scores (Kantarci et al., 2010). Given that α-synuclein accumulation in the amygdala has also been observed in DLB, this may implicate the amygdala as an important structure in the pathogenesis of DLB. To our knowledge this is the first study utilizing DTI to assess brainstem structures, such as the
midbrain and pons in DLB. There has also been a relative lack of studies investigating amygdala and thalamic diffusivity change in subcortical structures, which have been implicated in the pathogenesis of DLB that may help distinguish DLB from other dementias and normal aging (Watson et al., 2012a). Therefore using region of interest (ROI) methods, we investigated diffusion parameters in subjects with DLB, AD, and similar aged controls in thalamus, precuneus, pons, midbrain, and amygdala. We also studied the relationship between the diffusion measures and various clinical and neuropsychological variables in AD and DLB.
Methods Subjects Seventy one people with dementia (36 AD, 35 DLB) over the age of sixty were recruited from a community dwelling population of patients referred to geographically representative Old Age Psychiatry, Geriatric Medicine or Neurology Services. Informed consent was obtained from all subjects and where appropriate, their nearest relative provided written informed consent. Thirtyfive healthy controls of similar age and gender were also included in the study. They were recruited from relatives and friends of those with dementia, or volunteered via advertisements in local community newsletters. Those with evidence of dementia, depression, or a history of neurological, psychological, or psychiatric problems were excluded. All subjects were aged over 60 and did not have any contraindications for MRI. The research was approved by the local ethics committee. Diagnosis and assessment Diagnosis and assessment of study participants has been reported (Watson et al., 2012b). Diagnoses of AD and DLB were made in accordance with NINCDS-ADRDA (McKhann et al., 1984) and DLB consensus criteria (McKeith et al., 1996, 2005) respectively, by consensus agreement among three experienced raters (RB, JO’B, and RW) blinded to all information from the MRI scans. Assessment of global cognitive measures included the CAMCOG, which incorporates the Mini-Mental State Examination (MMSE; Folstein et al., 1975). Depressive symptoms were measured using the 15-item Geriatric Depression Scale (Sheikh and Yesavage, 1986). Motor parkinsonism was assessed with the Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) (Fahn, 1987). For participants with dementia, neuropsychiatric features were assessed using the Neuropsychiatric
Diffusion tensor imaging in AD and DLB
Inventory (NPI) (Cummings et al., 1994), cognitive fluctuations were assessed using the Clinician’s Assessment of Fluctuation (Walker et al., 2000), and functional abilities were assessed using the Bristol Activities of Daily Living (Bucks et al., 1996). MRI acquisition Subjects underwent magnetic resonance (MR) scanning on a 3T MRI system (Intera Achieva scanner, Philips Medical Systems, Eindhoven, Netherlands) with an eight channel receiver head coil, within two months of the study assessment. DTI images were acquired using a Pulsed Gradient Spin Echo (PGSE) sequence and multislice single shot EPI readout, with TE = 71 ms and TR = 2,524 ms. The image volumes were angulated such that the axial slice orientation was standardized to align with the AC-PC line with 2 mm in-plane resolution, 6 mm slice thickness, and matrix size of 128 (anterior-posterior) × 128 (right-left) × 24 (superior-inferior). The scan was accelerated with a sensitivity encoding (SENSE) factor of 2 in the anterior-posterior direction and reconstructed with the Cepstral Loudness Enhanced Algorithm (CLEAR) algorithm. Diffusion weighting was achieved by applying diffusion sensitizing gradient pulses with measurements made in 16 directions with a b value of 1,000 mm s−2 . DTI preprocessing and analysis The functional MRI of the Brain (FMRIB) software library (FSL) program was used to process and analyze raw DTI data (Smith et al., 2004) accessed at www.fmrib.ox.ac.uk/fsl. To correct for the distorting effect of eddy currents, we adapted the approach of Shen et al. (2004) and used an affine registration, in FSL’s FLIRT (FMRIB’s Linear Image Registration Tool) to register pairs of diffusion weighted images together. The eddy corrected diffusion weighted images were then transformed using a rigid body registration to the b = 0 mm s−2 image. The MD and FA images were calculated using FSL tensor analysis of the aligned diffusion weighted images at each brain voxel. ROI analysis For each subject, diffusion images (FA, MD) were initially coregistered to their corresponding T1 weighted MRI scans. Using the ITK-snap software (Yushkevich et al., 2006), a series of fixed square ROIs were manually placed on selected brain regions including thalamus (L, R), precuneus (L, R), pons, midbrain, and amygdala (L, R) onto
629
the subjects’ T1 MRI scan as shown in Figure 1 A–E respectively. The regions varied in size: for thalamus, pons, and midbrain, 4 × 4 pixels; and for precuneus and amygdala, 2 × 2 pixels. These ROIs were drawn according to a set protocol assessing axial, sagittal, and coronal views along with information from a human brain atlas (Mai et al., 1997). Optimal placement of regions was undertaken in order to try and avoid cerebrospinal fluid and WM hyperintensities. We identified a white matter tract for the precuneus, located using a consistent method for each scan (Figure 2). The T1 MRI-defined ROIs were then projected onto their FA and MD images where their co-ordinates (cross-hairs) were recorded and subsequently mean FA and MD counts per voxel within these regions were calculated. For thalamus, precuneus, and amygdala, left and right values were averaged. Statistical analysis Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) version 19 (www.ibm.com/software/analytics/spss/ products/statistics). Data were assessed for normality by visual inspection of variable histograms and use of the Shapiro-Wilk test. Where appropriate, demographical and imaging variables were examined using parametric (Analysis of one way variance (ANOVA), two sample t-test) and non-parametric (χ2 e, Mann Whitney U) methods. Bonferroni post hoc tests were performed as required. To assess the relationship between FA and MD values with clinical measures, a one-tailed Pearson’s partial correlation coefficient was used, controlling for age and MMSE score. After adjusting for multiple statistical testing, a corrected p-value of † Student’s t-test (AD
76.7 (5.2) 20/14 28.1 (1.0) 97.3 (3.8) 6.60 (0.7) NA 2.0 (1.9)
78.3 (5.8) 21/14 19.5 (4.4) 65.8 (12.1) 4.78 (2.0) 14.1 (7.2) 5.6 (4.3)
78.4 (6.9) 27/8 20.3 (5.3) 67.7 (15.3) 3.51 (2.4) 18.2 (9.6) 26.0 (10.7)
F2,103 = 0.8, p = 0.5 χ2 = 3.9, p = 0.2 t69 = 0.7, p = 0.5† t69 = 0.6, p = 0.6† t69 = 2.4, p = 0.019∗,† t66 = 2.0, p = 0.04† t69 = 10.6, p < 0.001†
DLB, AD (p < 0.001). vs. DLB). Note: Values expressed as mean (1SD). Bold text denotes significant group differences. DLB = dementia with Lewy bodies; AD = Alzheimer’s disease; NC = Normal Control; MMSE = Mini-Mental State Examination; CAMCOG = Cambridge Cognitive Examination; Bristol ADL = Bristol Activities of Daily Living; UPDRS III = Unified Parkinson’s Disease Rating Scale, Part III.
632
J. O’Donovan et al.
Table 2. FA and MD values NC
AD
P -V A L U E
DLB
............................................................................................................................................................................................................................................................................................................................
Thalamus FA Precuneus FA Pons FA Midbrain FA Amygdala FA Thalamus MD Precuneus MD Pons MD Midbrain MD Amygdala MD
0.280 (0.041) 0.458 (0.071) 0.327 (0.041) 0.432 (0.05) 0.142 (0.04) 752 (49) 708 (50) 779 (12) 728 (68) 857 (150)
0.294 (0.051) 0.406 (0.074) 0.343 (0.052) 0.432 (0.05) 0.134 (0.041) 756 (42) 768 (74) 756 (82) 740 (54) 896 (140)
0.294 (0.04) 0.403 (0.093) 0.321 (0.056) 0.430 (0.056) 0.126 (0.025) 771 (50) 766 (97) 771 (99) 751 (65) 835 (81)
F = 1.06, p = 0.350 F = 5.11, p = 0.008∗∗ F = 1.69, p = 0.190 F = 0.02, p = 0.985 F = 1.50, p = 0.228 F = 1.57, p = 0.213 F = 6.80, p = 0.002∗∗∗ F = 0.43, p = 0.653 F = 1.21, p = 0.302 F = 1.97, p = 0.145
∗∗ Post hoc Bonferroni test; Control > AD (p = 0.026), Control > DLB (p = 0.016). ∗∗∗ Post hoc Bonferroni test; AD > Control (p = 0.005), DLB > Control (p = 0.007).
Note: Otherwise post hoc Bonferroni test non-significant. Values expressed as mean (1 SD).
Table 3. ICC values for intra-rater agreement THALAMUS
PRECUNEUS
PONS
MIDBRAIN
AMYGDALA
............................................................................................................................................................................................................................................................................................................................
FA MD
0.946 0.980
0.827 0.991
between MD and UPDRS-III score was identified in the amygdala in DLB (r’ = 0.486, p = 0.006); however, we did not find a significant association between UPDRS and other regional DTI measures. Rater agreement Overall there was excellent intra-rater reliability with an average ICC of 0.867 for FA and 0.793 for MD. Intra-class correlation coefficient values for intra-rater agreement for each structure are summarized in Table 3.
Discussion This study utilized DTI as a means of assessing in vivo neurodegenerative changes in five key structures in a well characterized cohort of DLB, AD, and control subjects. The key findings of this study were: (i) mean FA in the precuneus was reduced in DLB and AD subjects, compared to controls; (ii) precuneal MD was elevated in AD and DLB subjects compared to controls; (iii) there were no significant differences in FA and MD in the thalamus, pons, midbrain, and amygdala between dementia subjects and controls or between dementia sub-groups; and (iv) controlling for age and MMSE, there was a statistically significant positive relationship between amygdala MD and UPDRS-III score in DLB. Precuneal FA was significantly reduced in DLB and AD compared to controls. The precuneus, which is part of the superior parietal lobe,
0.813 0.797
0.885 0.849
0.866 0.746
is involved in visuospatial processing, episodic memory retrieval, and self-processing operations (Cavanna and Trimble, 2006). Therefore, the finding of reduced FA in the precuneus in subjects with DLB is of interest given the characteristic visuoperceptual problems of the condition (McKeith et al., 2005). Similar changes have been reported previously (Firbank et al., 2007). In that study, which involved 16 subjects with DLB, 15 with AD and 16 controls, a significant decrease in FA in the precuneus in DLB was found (p = 0.009). It is possible that the reduced FA in the precuneus reflects microstructural damaged to the WM tracts. Our findings also add to data already obtained from SPECT studies, which demonstrate significant hypoperfusion in the precuneus in DLB subjects (Colloby et al., 2002; Kemp et al., 2005), showing the precuneus is potentially a key region affected in DLB. Subjects with AD also demonstrated reduced FA in the precuneus. This may reflect the overlap in the pathophysiology of AD and DLB. It may also reflect the nature of the disease process in AD, where typically there is more global atrophy than DLB, causing neuronal destruction and secondary WM degeneration (Whitwell et al., 2007). Therefore, although the precuneus appears to be affected in both conditions, it may be that in DLB it is more selectively damaged and in AD affected as part of the process of global atrophy (Watson et al., 2012a). However, given the apparent degree of overlap in these measures in AD and DLB, the technique is unlikely to be effective in
Diffusion tensor imaging in AD and DLB
terms of diagnostic utility in classifying AD and DLB, and therefore of limited use for individual case detection. A positive correlation between precuneal FA and MMSE was observed in subjects with AD (p = 0.032). This is similar to findings in a study by Frisoni et al., who used voxel-based morphometry to detect gray matter loss in AD. They found a correlation between gray matter loss in the precuneus and MMSE score (Frisoni et al., 2002). The degeneration of precuneal gray matter and the resulting disruption in connectivity, reflected by decreased FA, could contribute to the decline in overall cognitive function. However, this correlation was not observed in DLB, highlighting the differences in the pathological processes between AD and DLB. Motor parkinsonism was assessed using UPDRS-III score and correlated with elevated MD in the amygdala in DLB (r = 0.49, p = 0.006). The relationship between UPDRS-III score and MD in the amygdala was in agreement with an earlier DTI study by Kantarci et al. (2010) involving 30 subjects with DLB, demonstrating a relationship between amygdala diffusivity and UPDRS-III score (p = 0.005). The authors hypothesized that there was unlikely to be a direct structural-functional link between changes in the amygdala and parkinsonism (Kantarci et al., 2010). Rather, it was proposed that the high burden of Lewy bodies in the amygdala correlated with the high burden in the substantia nigra, causing features of parkinsonism (Kantarci et al., 2010). It is possible that the severity of parkinsonism, as measured by UPDRS-III, reflects Lewy body burden in the amygdala. These findings are interesting as various studies have shown that α-synuclein, a major component of Lewy bodies, aggregates in the amygdala (Popescu et al., 2004). Therefore, despite the correlation being modest, our finding of a relationship between UPDRS-III score and increased diffusivity in the amygdala supports the notion that the amygdala may be an important structure underpinning some of the key clinical features of DLB and could be assessed further using an alternative imaging technique such as multimodal MRI. Strengths of this study include the size of the DLB cohort, which is at present the largest cohort to complete a DTI study to date. The dementia groups were well matched for age and educational level. Although care was taken to ensure the control group did not display any features of cognitive impairment or dementia, some may well have preclinical disease, as has been shown studies of healthy older adults (Goldman et al., 2001; Rodrigue et al., 2012). Clinical measures were carefully preselected to assess potential correlations in order to decrease the risk of type I errors. There were several
633
study limitations. First, the lack of pathological diagnosis, as with all antemortem neuroimaging studies. However, inclusion was based on wellvalidated clinical diagnostic criteria. Second, like the majority of previous studies assessing DTI in DLB, manual ROI placement along with their associated errors were also used in this study. We attempted to reduce these errors by using the same method to locate structures in which the region was being placed. After the region had been placed in the selected area the sagittal, axial, and coronal views were then checked to ensure correct alignment. Third, the crossing fiber algorithm was not implemented as part of the preprocessing stream. As such, the images were not modeled for the number of crossing fibers. However, since we followed a strict protocol of ROI placement, we predict that such effects would be similar across all subjects and not significantly affect results. Thus, the findings should be interpreted with this in view. Forth, although excellent intra-rater agreement was observed, inter-rater agreement was not measured; therefore a full examination of the techniques reproducibility could not be achieved. Lastly, we may have included cerebrospinal fluid (CSF) or white matter hyperintensities (WMH) in the sampled regions, which would have affected the diffusion parameters leading to inconsistent results. In order to minimize this, we utilized relatively small ROI’s, which meant they were less likely to encroach on CSF or WMH’s that may surround the structure. Future studies could involve volumetric techniques given that cases with WMH were not excluded. To our knowledge, this was one of the largest DLB cohorts that were studied using DTI, and the first to assess midbrain, pons, and thalamus. Elevated MD and reduced FA were found in the WM tracts of the precuneus in DLB and AD compared to similar aged controls, suggesting that the precuneus is an important region of change in dementia, and potentially a marker of disease severity in AD. In DLB, amygdala diffusivity was associated with UPDRS-III score, which when combined with the known pathological changes further highlights the importance of the amygdala in the pathogenesis of DLB. Diffusion tensor MRI may help shed new light on the different neurobiological changes underpinning the key clinical features of DLB. Conflict of interest None. Description of authors’ roles J. O’Donovan completed the region of interest analysis, interpreted the results, and wrote the paper. R. Watson designed the study, co-supervised the
634
J. O’Donovan et al.
project, interpreted results, assessed study subjects and provided diagnostic ratings and reviewed the paper. S. Colloby assisted with study design, cosupervised the project, completed the statistical analysis, and reviewed the paper. A. Blamire reviewed the paper and secured funding for the project. J. O’Brien co-supervised the project, reviewed the paper, and secured funding of the project.
Acknowledgments We thank Dr Robert Barber for providing assistance with subject diagnostic rating as well as Josh Wood, Assistant Psychologist, and the members of North East Dementias and Neurodegenerative Diseases Research network (NE-DeNDRoN) for their assistance with recruitment and assessment of study participants. We are also grateful to all of the study volunteers for their involvement. The study was supported by the Sir Jules Thorn Charitable Trust (grant number 05/JTA), The Jean Shanks Foundation, and the UK NIHR Biomedical Research Centre and Biomedical Research Unit in Lewy body dementia awarded to the Newcastle upon Tyne Hospitals NHS Foundation Trust and the NIHR Biomedical Research Centre and Biomedical Research Unit in Dementia awarded to Cambridge University Hospitals NHS Trust and the University of Cambridge.
References Bozzali, M. et al. (2005). Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain, 128, 1595–1604. Bucks, R. S., Ashworth, D. L., Wilcock, G. K. and Siegfried, K. (1996). Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing, 25, 113–120. Cavanna, A. E. and Trimble, M. R. (2006). The precuneus: a review of its functional anatomy and behavioural correlates. Brain, 129, 564–583. Colloby, S. J. et al. (2002). A comparison of 99mTc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer’s disease using statistical parametric mapping. European Journal of Nuclear Medicine, 29, 615–622. Cummings, J. L. et al. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308–2314. Fahn, S., Elton, R. and Members of the UPDRS Development Committee (1987). Unified Parkinson’s Disease Rating Scale. Florham Park, NJ: Macmillan Healthcare Information. Firbank, M. J. et al. (2007). Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer’s disease. Psychiatry Research - Neuroimaging, 155, 135–145. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). Mini-mental state. A practical method for grading
the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198. Frisoni, G. B. et al. (2002). Detection of grey matter loss in mild Alzheimer’s disease with voxel based morphometry. Journal of Neurology Neurosurgery and Psychiatry, 73, 657–664. Goldman, W. P. et al. (2001). Absence of cognitive impairment or decline in preclinical Alzheimer’s disease. Neurology, 56, 361–367. Kantarci, K. et al. (2010). Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology, 74, 1814–1821. Kemp, P. M. et al. (2005). The contribution of statistical parametric mapping in the assessment of precuneal and medial temporal lobe perfusion by 99mTc-HMPAO SPECT in mild Alzheimer’s and Lewy body dementia. Nuclear Medicine Communications, 26, 1099–1106. Kiuchi, K. et al. (2011). White matter changes in dementia with Lewy bodies and Alzheimer’s disease: a tractographybased study. Journal of Psychiatric Research, 45, 1095–1100. Le Bihan, D. (2007). The “wet mind”: water and functional neuroimaging. Physics in Medicine and Biology, 52, R57–R90. Le Bihan, D., Breton, E. and Lallemand, D. (1986). MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology, 161, 401–407. Lee, J. E. et al. (2010). A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson’s disease dementia and dementia with Lewy bodies. Journal of Neurology, Neurosurgery and Psychiatry, 81, 320– 326. Litvan, I., Bhatia, K., Burn, D. J., Goetz, C. G., Lang, A. E. and Mckeith, I. G. (2003). Movement Disorders Society Scientific Issues Commitee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinson disorders. Movement Disorders, 18, 467–486. Mai, J., Assheuer, J. and Paxinos, G. (1997). Atlas of the Human Brain. San Diego, CA: Academic Press. McKeith, I. G. et al. (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology, 47, 1113–1124. McKeith, I. G. et al. (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology, 65, 1863–1872. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34, 939–944. Medina, D. A. and Gaviria, M. (2008). Diffusion tensor imaging investigations in Alzheimer’s disease: the resurgence of white matter compromise in the cortical dysfunction of the aging brain. Neuropsychiatric Disease and Treatment, 4, 737–742. Minati, L., Grisoli, M. and Bruzzone, M. G. (2007). MR spectroscopy, functional MRI, and diffusion-tensor imaging in the aging brain: a conceptual review. Journal of Geriatric Psychiatry and Neurology, 20, 3–21.
Diffusion tensor imaging in AD and DLB Mori, S. and Zhang, J. (2006). Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron, 51, 527–539. Ota, M. et al. (2009). Degeneration of dementia with Lewy bodies measured by diffusion tensor imaging. NMR in Biomedicine, 22, 280–284. Popescu, A., Lippa, C. F., Lee, V. M. Y. and Trojanowski, J. Q. (2004). Lewy bodies in the amygdala: increase of α -synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Archives of Neurology, 61, 1915–1919. Ringman, J. M. et al. (2007). Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer’s disease mutations. Brain, 130, 1767– 1776. Rodrigue, K. M. et al. (2012). β -amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology, 78, 387–395. Sheikh, J. I. and Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clinical Gerontology, 5, 165–173. Shen, Y. et al. (2004). Correction of high-order eddy current induced geometric distortion in diffusion-weighted echo-planar images. Magnetic Resonance in Medicine, 52, 1184–1189. Smith, S. M. et al. (2004). Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage, 23, S208–S219.
635
Vasconcelos, L. G., Brucki, S. M. D., Jackowiski, A. P. and Bueno, O. F. A. (2009). Diffusion tensor imaging for Alzheimer’s disease: a review of concepts and potential clinical applicability. Imagem do tensor de difusão na doença de Alzheimer: Revisão De Conceitos e Potenciais Aplicabilidades Clínicas, 3, 268–274. Walker, M. P. et al. (2000). Quantification and characterisation of fluctuating cognition in dementia with Lewy bodies and Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders, 11, 327–335. Watson, R. and O’Brien, J. T. (2012). Differentiating dementia with Lewy bodies and Alzheimer’s disease using MRI. Neurodegenerative Disease Management, 2, 1– 10. Watson, R. et al. (2012a). Characterizing dementia with Lewy bodies by means of diffusion tensor imaging. Neurology, 79, 906–914. Watson, R., O’Brien, J. T., Barber, R. and Blamire, A. M. (2012b). Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study. International Psychogeriatrics, 24, 532–540. Whitwell, J. L. et al. (2007). Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer’s disease. Brain, 130, 708–719. Yushkevich, P. A. et al. (2006). User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage, 31, 1116–1128.
Assessment of regional MR diffusion changes in dementia with Lewy bodies and Alzheimer’s disease ...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................
James O’Donovan,1 Rosie Watson,1 Sean J. Colloby,1 Andrew. M. Blamire3 and John T. O’Brien1,2 1
Institute for Ageing and Health, Campus for Ageing and Vitality, Newcastle University, Newcastle-upon-Tyne, UK Department of Psychiatry, Addenbrooke’s Hospital, University of Cambridge, Cambridge, UK 3 Newcastle Magnetic Resonance Centre and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK 2
ABSTRACT
Background: Dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD) are common forms of dementia, yet diagnosis is often difficult. Diffusion tensor imaging (DTI) is an MR technique used to assess neuronal microstructural integrity that may help develop a better understanding of the differences between the conditions. Methods: We recruited subjects with DLB (n = 35), AD (n = 36), and similar aged healthy controls (n = 35). T1 weighted anatomical and diffusion MR images were acquired at 3 Tesla. Region of interest (ROI) analysis was used to measure fractional anisotropy (FA) and mean diffusivity (MD) in five structures: precuneus, thalamus, pons, midbrain, and amygdala. Where appropriate diffusivity measures (FA, MD) were correlated with selected clinical measures. Results: Compared to controls, DLB subjects were characterized by reduced FA (p = 0.016) and increased MD (p = 0.007) in the precuneus. Amygdala diffusivity was positively correlated with UPDRS-III score in DLB (p = 0.003). In AD, reduced FA in the precuneus was also observed compared to controls (p = 0.026), and was associated with impaired global cognition (MMSE score) (p = 0.03). Conclusions: Our findings highlight the potential importance of the precuneus in the pathogenesis of DLB as well as AD. Diffusion tensor MRI may shed new light on the different neurobiological changes underpinning the key clinical features of DLB and AD. Key words: DLB, Lewy, dementia, Alzheimer’s disease, diffusion tensor imaging, MRI
Introduction The most common subtypes of dementia in later life are Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB). Distinguishing between AD and DLB during life can be difficult as symptoms between the two conditions often overlap especially in the advanced stages of the disease. The clinical diagnostic criteria for DLB also lack sensitivity so that many cases are missed or misdiagnosed (Litvan et al., 2003). Furthermore, neuroimaging changes in dementia can also overlap with those seen in normal aging (Minati et al., 2007). Structural neuroimaging, including magnetic resonance imaging (MRI), is an important part Correspondence should be addressed to: Dr. Sean Colloby, Institute for Ageing and Health, Campus for Ageing and Vitality, Newcastle University, Newcastleupon-Tyne, UK. Phone: +44-191-248-1321; Fax: +44-191-248-1301. Email: [email protected]. Received 17 Aug 2013; revision requested 15 Sep 2013; revised version received 5 Oct 2013; accepted 4 Nov 2013. First published online 16 December 2013.
of the clinical work up for all patients with dementia. More recently an advanced MRI method, diffusion tensor imaging (DTI), has emerged as a technique to assess the microstructure of the brain. It is thought that DTI may be a more sensitive neuroimaging procedure compared to conventional structural MRI, as it may detect subtle preclinical changes (Ringman et al., 2007). DTI is an advanced MRI technique that allows assessment of the tissue microstructure by measuring the incoherent motion of water molecules (Le Bihan et al., 1986). The diffusion of molecules in tissues varies depending on the interactions with obstacles such as tissue membranes and fibers (Le Bihan, 2007). White matter tracts in the brain have a fibrous internal structure, meaning that the diffusion of water along these tracts is directionally dependent; a property known as anisotropy (Mori and Zhang, 2006). Water molecules will diffuse further along a tract if aligned in the same direction, as theoretically there are “fewer obstacles to prevent movement”
628
J. O’Donovan et al.
(Mori and Zhang, 2006). There are two important measures that can be derived from DTI; Mean diffusivity (MD) and Fractional anisotropy (FA). MD represents the overall displacement of water molecules whereas FA quantifies the directionality of local tract structure. Typically DTI abnormalities are represented by increased MD and/or reduced FA. For example, an FA value of 0 would indicate that the diffusion of water molecules is the same in all directions, whereas a value of 1 would indicate diffusivity of molecules in a single direction. When there is damage to the walls of the axons, FA will decrease as the water molecules adopt a more random direction of diffusion. It is thought that when combined with the macro-structural changes on conventional MRI scanning, DTI may be used to assist with earlier diagnosis of different dementia subtypes. There have been a number of diffusion imaging studies in AD (Vasconcelos et al., 2009), the majority of which have compared AD and similar aged controls or with subjects with mild cognitive impairment. The most consistent findings are that posterior brain regions seem to be more affected than anterior regions during the early stages of AD, then, as the disease progresses, the limbic and frontal structures also become involved followed lastly by the primary sensorimotor regions, which have been shown to correlate with the clinical manifestations of the disease (Medina and Gaviria, 2008). There have been fewer studies in DLB and with varying results (Watson and O’Brien, 2012). Some studies report widespread diffusivity changes in comparison to healthy controls (Bozzali et al., 2005; Lee et al., 2010), whereas others report little to no change (Firbank et al., 2007; Kantarci et al., 2010). Most DTI studies in DLB have utilized analysis methods that focus on cortical structures and key neuronal WM tracts. The most consistent findings have been changes in the Inferior Longitudinal Fasciculus (ILF) and precuneal WM tracts, which form part of the ventral and dorsal visual streams respectively (Ota et al., 2009; Kantarci et al., 2010; Kiuchi et al., 2011; Watson et al., 2012a). These findings are particularly interesting given that visuoperceptual impairments and visual hallucinations are common in DLB (McKeith et al., 2005). A study in 2010 by Kantarci et al., revealed increased diffusivity in the amygdala in DLB compared to controls (Kantarci et al., 2010), which also correlated with the UPDRS-III scores (Kantarci et al., 2010). Given that α-synuclein accumulation in the amygdala has also been observed in DLB, this may implicate the amygdala as an important structure in the pathogenesis of DLB. To our knowledge this is the first study utilizing DTI to assess brainstem structures, such as the
midbrain and pons in DLB. There has also been a relative lack of studies investigating amygdala and thalamic diffusivity change in subcortical structures, which have been implicated in the pathogenesis of DLB that may help distinguish DLB from other dementias and normal aging (Watson et al., 2012a). Therefore using region of interest (ROI) methods, we investigated diffusion parameters in subjects with DLB, AD, and similar aged controls in thalamus, precuneus, pons, midbrain, and amygdala. We also studied the relationship between the diffusion measures and various clinical and neuropsychological variables in AD and DLB.
Methods Subjects Seventy one people with dementia (36 AD, 35 DLB) over the age of sixty were recruited from a community dwelling population of patients referred to geographically representative Old Age Psychiatry, Geriatric Medicine or Neurology Services. Informed consent was obtained from all subjects and where appropriate, their nearest relative provided written informed consent. Thirtyfive healthy controls of similar age and gender were also included in the study. They were recruited from relatives and friends of those with dementia, or volunteered via advertisements in local community newsletters. Those with evidence of dementia, depression, or a history of neurological, psychological, or psychiatric problems were excluded. All subjects were aged over 60 and did not have any contraindications for MRI. The research was approved by the local ethics committee. Diagnosis and assessment Diagnosis and assessment of study participants has been reported (Watson et al., 2012b). Diagnoses of AD and DLB were made in accordance with NINCDS-ADRDA (McKhann et al., 1984) and DLB consensus criteria (McKeith et al., 1996, 2005) respectively, by consensus agreement among three experienced raters (RB, JO’B, and RW) blinded to all information from the MRI scans. Assessment of global cognitive measures included the CAMCOG, which incorporates the Mini-Mental State Examination (MMSE; Folstein et al., 1975). Depressive symptoms were measured using the 15-item Geriatric Depression Scale (Sheikh and Yesavage, 1986). Motor parkinsonism was assessed with the Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) (Fahn, 1987). For participants with dementia, neuropsychiatric features were assessed using the Neuropsychiatric
Diffusion tensor imaging in AD and DLB
Inventory (NPI) (Cummings et al., 1994), cognitive fluctuations were assessed using the Clinician’s Assessment of Fluctuation (Walker et al., 2000), and functional abilities were assessed using the Bristol Activities of Daily Living (Bucks et al., 1996). MRI acquisition Subjects underwent magnetic resonance (MR) scanning on a 3T MRI system (Intera Achieva scanner, Philips Medical Systems, Eindhoven, Netherlands) with an eight channel receiver head coil, within two months of the study assessment. DTI images were acquired using a Pulsed Gradient Spin Echo (PGSE) sequence and multislice single shot EPI readout, with TE = 71 ms and TR = 2,524 ms. The image volumes were angulated such that the axial slice orientation was standardized to align with the AC-PC line with 2 mm in-plane resolution, 6 mm slice thickness, and matrix size of 128 (anterior-posterior) × 128 (right-left) × 24 (superior-inferior). The scan was accelerated with a sensitivity encoding (SENSE) factor of 2 in the anterior-posterior direction and reconstructed with the Cepstral Loudness Enhanced Algorithm (CLEAR) algorithm. Diffusion weighting was achieved by applying diffusion sensitizing gradient pulses with measurements made in 16 directions with a b value of 1,000 mm s−2 . DTI preprocessing and analysis The functional MRI of the Brain (FMRIB) software library (FSL) program was used to process and analyze raw DTI data (Smith et al., 2004) accessed at www.fmrib.ox.ac.uk/fsl. To correct for the distorting effect of eddy currents, we adapted the approach of Shen et al. (2004) and used an affine registration, in FSL’s FLIRT (FMRIB’s Linear Image Registration Tool) to register pairs of diffusion weighted images together. The eddy corrected diffusion weighted images were then transformed using a rigid body registration to the b = 0 mm s−2 image. The MD and FA images were calculated using FSL tensor analysis of the aligned diffusion weighted images at each brain voxel. ROI analysis For each subject, diffusion images (FA, MD) were initially coregistered to their corresponding T1 weighted MRI scans. Using the ITK-snap software (Yushkevich et al., 2006), a series of fixed square ROIs were manually placed on selected brain regions including thalamus (L, R), precuneus (L, R), pons, midbrain, and amygdala (L, R) onto
629
the subjects’ T1 MRI scan as shown in Figure 1 A–E respectively. The regions varied in size: for thalamus, pons, and midbrain, 4 × 4 pixels; and for precuneus and amygdala, 2 × 2 pixels. These ROIs were drawn according to a set protocol assessing axial, sagittal, and coronal views along with information from a human brain atlas (Mai et al., 1997). Optimal placement of regions was undertaken in order to try and avoid cerebrospinal fluid and WM hyperintensities. We identified a white matter tract for the precuneus, located using a consistent method for each scan (Figure 2). The T1 MRI-defined ROIs were then projected onto their FA and MD images where their co-ordinates (cross-hairs) were recorded and subsequently mean FA and MD counts per voxel within these regions were calculated. For thalamus, precuneus, and amygdala, left and right values were averaged. Statistical analysis Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) version 19 (www.ibm.com/software/analytics/spss/ products/statistics). Data were assessed for normality by visual inspection of variable histograms and use of the Shapiro-Wilk test. Where appropriate, demographical and imaging variables were examined using parametric (Analysis of one way variance (ANOVA), two sample t-test) and non-parametric (χ2 e, Mann Whitney U) methods. Bonferroni post hoc tests were performed as required. To assess the relationship between FA and MD values with clinical measures, a one-tailed Pearson’s partial correlation coefficient was used, controlling for age and MMSE score. After adjusting for multiple statistical testing, a corrected p-value of † Student’s t-test (AD
76.7 (5.2) 20/14 28.1 (1.0) 97.3 (3.8) 6.60 (0.7) NA 2.0 (1.9)
78.3 (5.8) 21/14 19.5 (4.4) 65.8 (12.1) 4.78 (2.0) 14.1 (7.2) 5.6 (4.3)
78.4 (6.9) 27/8 20.3 (5.3) 67.7 (15.3) 3.51 (2.4) 18.2 (9.6) 26.0 (10.7)
F2,103 = 0.8, p = 0.5 χ2 = 3.9, p = 0.2 t69 = 0.7, p = 0.5† t69 = 0.6, p = 0.6† t69 = 2.4, p = 0.019∗,† t66 = 2.0, p = 0.04† t69 = 10.6, p < 0.001†
DLB, AD (p < 0.001). vs. DLB). Note: Values expressed as mean (1SD). Bold text denotes significant group differences. DLB = dementia with Lewy bodies; AD = Alzheimer’s disease; NC = Normal Control; MMSE = Mini-Mental State Examination; CAMCOG = Cambridge Cognitive Examination; Bristol ADL = Bristol Activities of Daily Living; UPDRS III = Unified Parkinson’s Disease Rating Scale, Part III.
632
J. O’Donovan et al.
Table 2. FA and MD values NC
AD
P -V A L U E
DLB
............................................................................................................................................................................................................................................................................................................................
Thalamus FA Precuneus FA Pons FA Midbrain FA Amygdala FA Thalamus MD Precuneus MD Pons MD Midbrain MD Amygdala MD
0.280 (0.041) 0.458 (0.071) 0.327 (0.041) 0.432 (0.05) 0.142 (0.04) 752 (49) 708 (50) 779 (12) 728 (68) 857 (150)
0.294 (0.051) 0.406 (0.074) 0.343 (0.052) 0.432 (0.05) 0.134 (0.041) 756 (42) 768 (74) 756 (82) 740 (54) 896 (140)
0.294 (0.04) 0.403 (0.093) 0.321 (0.056) 0.430 (0.056) 0.126 (0.025) 771 (50) 766 (97) 771 (99) 751 (65) 835 (81)
F = 1.06, p = 0.350 F = 5.11, p = 0.008∗∗ F = 1.69, p = 0.190 F = 0.02, p = 0.985 F = 1.50, p = 0.228 F = 1.57, p = 0.213 F = 6.80, p = 0.002∗∗∗ F = 0.43, p = 0.653 F = 1.21, p = 0.302 F = 1.97, p = 0.145
∗∗ Post hoc Bonferroni test; Control > AD (p = 0.026), Control > DLB (p = 0.016). ∗∗∗ Post hoc Bonferroni test; AD > Control (p = 0.005), DLB > Control (p = 0.007).
Note: Otherwise post hoc Bonferroni test non-significant. Values expressed as mean (1 SD).
Table 3. ICC values for intra-rater agreement THALAMUS
PRECUNEUS
PONS
MIDBRAIN
AMYGDALA
............................................................................................................................................................................................................................................................................................................................
FA MD
0.946 0.980
0.827 0.991
between MD and UPDRS-III score was identified in the amygdala in DLB (r’ = 0.486, p = 0.006); however, we did not find a significant association between UPDRS and other regional DTI measures. Rater agreement Overall there was excellent intra-rater reliability with an average ICC of 0.867 for FA and 0.793 for MD. Intra-class correlation coefficient values for intra-rater agreement for each structure are summarized in Table 3.
Discussion This study utilized DTI as a means of assessing in vivo neurodegenerative changes in five key structures in a well characterized cohort of DLB, AD, and control subjects. The key findings of this study were: (i) mean FA in the precuneus was reduced in DLB and AD subjects, compared to controls; (ii) precuneal MD was elevated in AD and DLB subjects compared to controls; (iii) there were no significant differences in FA and MD in the thalamus, pons, midbrain, and amygdala between dementia subjects and controls or between dementia sub-groups; and (iv) controlling for age and MMSE, there was a statistically significant positive relationship between amygdala MD and UPDRS-III score in DLB. Precuneal FA was significantly reduced in DLB and AD compared to controls. The precuneus, which is part of the superior parietal lobe,
0.813 0.797
0.885 0.849
0.866 0.746
is involved in visuospatial processing, episodic memory retrieval, and self-processing operations (Cavanna and Trimble, 2006). Therefore, the finding of reduced FA in the precuneus in subjects with DLB is of interest given the characteristic visuoperceptual problems of the condition (McKeith et al., 2005). Similar changes have been reported previously (Firbank et al., 2007). In that study, which involved 16 subjects with DLB, 15 with AD and 16 controls, a significant decrease in FA in the precuneus in DLB was found (p = 0.009). It is possible that the reduced FA in the precuneus reflects microstructural damaged to the WM tracts. Our findings also add to data already obtained from SPECT studies, which demonstrate significant hypoperfusion in the precuneus in DLB subjects (Colloby et al., 2002; Kemp et al., 2005), showing the precuneus is potentially a key region affected in DLB. Subjects with AD also demonstrated reduced FA in the precuneus. This may reflect the overlap in the pathophysiology of AD and DLB. It may also reflect the nature of the disease process in AD, where typically there is more global atrophy than DLB, causing neuronal destruction and secondary WM degeneration (Whitwell et al., 2007). Therefore, although the precuneus appears to be affected in both conditions, it may be that in DLB it is more selectively damaged and in AD affected as part of the process of global atrophy (Watson et al., 2012a). However, given the apparent degree of overlap in these measures in AD and DLB, the technique is unlikely to be effective in
Diffusion tensor imaging in AD and DLB
terms of diagnostic utility in classifying AD and DLB, and therefore of limited use for individual case detection. A positive correlation between precuneal FA and MMSE was observed in subjects with AD (p = 0.032). This is similar to findings in a study by Frisoni et al., who used voxel-based morphometry to detect gray matter loss in AD. They found a correlation between gray matter loss in the precuneus and MMSE score (Frisoni et al., 2002). The degeneration of precuneal gray matter and the resulting disruption in connectivity, reflected by decreased FA, could contribute to the decline in overall cognitive function. However, this correlation was not observed in DLB, highlighting the differences in the pathological processes between AD and DLB. Motor parkinsonism was assessed using UPDRS-III score and correlated with elevated MD in the amygdala in DLB (r = 0.49, p = 0.006). The relationship between UPDRS-III score and MD in the amygdala was in agreement with an earlier DTI study by Kantarci et al. (2010) involving 30 subjects with DLB, demonstrating a relationship between amygdala diffusivity and UPDRS-III score (p = 0.005). The authors hypothesized that there was unlikely to be a direct structural-functional link between changes in the amygdala and parkinsonism (Kantarci et al., 2010). Rather, it was proposed that the high burden of Lewy bodies in the amygdala correlated with the high burden in the substantia nigra, causing features of parkinsonism (Kantarci et al., 2010). It is possible that the severity of parkinsonism, as measured by UPDRS-III, reflects Lewy body burden in the amygdala. These findings are interesting as various studies have shown that α-synuclein, a major component of Lewy bodies, aggregates in the amygdala (Popescu et al., 2004). Therefore, despite the correlation being modest, our finding of a relationship between UPDRS-III score and increased diffusivity in the amygdala supports the notion that the amygdala may be an important structure underpinning some of the key clinical features of DLB and could be assessed further using an alternative imaging technique such as multimodal MRI. Strengths of this study include the size of the DLB cohort, which is at present the largest cohort to complete a DTI study to date. The dementia groups were well matched for age and educational level. Although care was taken to ensure the control group did not display any features of cognitive impairment or dementia, some may well have preclinical disease, as has been shown studies of healthy older adults (Goldman et al., 2001; Rodrigue et al., 2012). Clinical measures were carefully preselected to assess potential correlations in order to decrease the risk of type I errors. There were several
633
study limitations. First, the lack of pathological diagnosis, as with all antemortem neuroimaging studies. However, inclusion was based on wellvalidated clinical diagnostic criteria. Second, like the majority of previous studies assessing DTI in DLB, manual ROI placement along with their associated errors were also used in this study. We attempted to reduce these errors by using the same method to locate structures in which the region was being placed. After the region had been placed in the selected area the sagittal, axial, and coronal views were then checked to ensure correct alignment. Third, the crossing fiber algorithm was not implemented as part of the preprocessing stream. As such, the images were not modeled for the number of crossing fibers. However, since we followed a strict protocol of ROI placement, we predict that such effects would be similar across all subjects and not significantly affect results. Thus, the findings should be interpreted with this in view. Forth, although excellent intra-rater agreement was observed, inter-rater agreement was not measured; therefore a full examination of the techniques reproducibility could not be achieved. Lastly, we may have included cerebrospinal fluid (CSF) or white matter hyperintensities (WMH) in the sampled regions, which would have affected the diffusion parameters leading to inconsistent results. In order to minimize this, we utilized relatively small ROI’s, which meant they were less likely to encroach on CSF or WMH’s that may surround the structure. Future studies could involve volumetric techniques given that cases with WMH were not excluded. To our knowledge, this was one of the largest DLB cohorts that were studied using DTI, and the first to assess midbrain, pons, and thalamus. Elevated MD and reduced FA were found in the WM tracts of the precuneus in DLB and AD compared to similar aged controls, suggesting that the precuneus is an important region of change in dementia, and potentially a marker of disease severity in AD. In DLB, amygdala diffusivity was associated with UPDRS-III score, which when combined with the known pathological changes further highlights the importance of the amygdala in the pathogenesis of DLB. Diffusion tensor MRI may help shed new light on the different neurobiological changes underpinning the key clinical features of DLB. Conflict of interest None. Description of authors’ roles J. O’Donovan completed the region of interest analysis, interpreted the results, and wrote the paper. R. Watson designed the study, co-supervised the
634
J. O’Donovan et al.
project, interpreted results, assessed study subjects and provided diagnostic ratings and reviewed the paper. S. Colloby assisted with study design, cosupervised the project, completed the statistical analysis, and reviewed the paper. A. Blamire reviewed the paper and secured funding for the project. J. O’Brien co-supervised the project, reviewed the paper, and secured funding of the project.
Acknowledgments We thank Dr Robert Barber for providing assistance with subject diagnostic rating as well as Josh Wood, Assistant Psychologist, and the members of North East Dementias and Neurodegenerative Diseases Research network (NE-DeNDRoN) for their assistance with recruitment and assessment of study participants. We are also grateful to all of the study volunteers for their involvement. The study was supported by the Sir Jules Thorn Charitable Trust (grant number 05/JTA), The Jean Shanks Foundation, and the UK NIHR Biomedical Research Centre and Biomedical Research Unit in Lewy body dementia awarded to the Newcastle upon Tyne Hospitals NHS Foundation Trust and the NIHR Biomedical Research Centre and Biomedical Research Unit in Dementia awarded to Cambridge University Hospitals NHS Trust and the University of Cambridge.
References Bozzali, M. et al. (2005). Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain, 128, 1595–1604. Bucks, R. S., Ashworth, D. L., Wilcock, G. K. and Siegfried, K. (1996). Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing, 25, 113–120. Cavanna, A. E. and Trimble, M. R. (2006). The precuneus: a review of its functional anatomy and behavioural correlates. Brain, 129, 564–583. Colloby, S. J. et al. (2002). A comparison of 99mTc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer’s disease using statistical parametric mapping. European Journal of Nuclear Medicine, 29, 615–622. Cummings, J. L. et al. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308–2314. Fahn, S., Elton, R. and Members of the UPDRS Development Committee (1987). Unified Parkinson’s Disease Rating Scale. Florham Park, NJ: Macmillan Healthcare Information. Firbank, M. J. et al. (2007). Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer’s disease. Psychiatry Research - Neuroimaging, 155, 135–145. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). Mini-mental state. A practical method for grading
the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198. Frisoni, G. B. et al. (2002). Detection of grey matter loss in mild Alzheimer’s disease with voxel based morphometry. Journal of Neurology Neurosurgery and Psychiatry, 73, 657–664. Goldman, W. P. et al. (2001). Absence of cognitive impairment or decline in preclinical Alzheimer’s disease. Neurology, 56, 361–367. Kantarci, K. et al. (2010). Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology, 74, 1814–1821. Kemp, P. M. et al. (2005). The contribution of statistical parametric mapping in the assessment of precuneal and medial temporal lobe perfusion by 99mTc-HMPAO SPECT in mild Alzheimer’s and Lewy body dementia. Nuclear Medicine Communications, 26, 1099–1106. Kiuchi, K. et al. (2011). White matter changes in dementia with Lewy bodies and Alzheimer’s disease: a tractographybased study. Journal of Psychiatric Research, 45, 1095–1100. Le Bihan, D. (2007). The “wet mind”: water and functional neuroimaging. Physics in Medicine and Biology, 52, R57–R90. Le Bihan, D., Breton, E. and Lallemand, D. (1986). MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology, 161, 401–407. Lee, J. E. et al. (2010). A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson’s disease dementia and dementia with Lewy bodies. Journal of Neurology, Neurosurgery and Psychiatry, 81, 320– 326. Litvan, I., Bhatia, K., Burn, D. J., Goetz, C. G., Lang, A. E. and Mckeith, I. G. (2003). Movement Disorders Society Scientific Issues Commitee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinson disorders. Movement Disorders, 18, 467–486. Mai, J., Assheuer, J. and Paxinos, G. (1997). Atlas of the Human Brain. San Diego, CA: Academic Press. McKeith, I. G. et al. (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology, 47, 1113–1124. McKeith, I. G. et al. (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology, 65, 1863–1872. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34, 939–944. Medina, D. A. and Gaviria, M. (2008). Diffusion tensor imaging investigations in Alzheimer’s disease: the resurgence of white matter compromise in the cortical dysfunction of the aging brain. Neuropsychiatric Disease and Treatment, 4, 737–742. Minati, L., Grisoli, M. and Bruzzone, M. G. (2007). MR spectroscopy, functional MRI, and diffusion-tensor imaging in the aging brain: a conceptual review. Journal of Geriatric Psychiatry and Neurology, 20, 3–21.
Diffusion tensor imaging in AD and DLB Mori, S. and Zhang, J. (2006). Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron, 51, 527–539. Ota, M. et al. (2009). Degeneration of dementia with Lewy bodies measured by diffusion tensor imaging. NMR in Biomedicine, 22, 280–284. Popescu, A., Lippa, C. F., Lee, V. M. Y. and Trojanowski, J. Q. (2004). Lewy bodies in the amygdala: increase of α -synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Archives of Neurology, 61, 1915–1919. Ringman, J. M. et al. (2007). Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer’s disease mutations. Brain, 130, 1767– 1776. Rodrigue, K. M. et al. (2012). β -amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology, 78, 387–395. Sheikh, J. I. and Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clinical Gerontology, 5, 165–173. Shen, Y. et al. (2004). Correction of high-order eddy current induced geometric distortion in diffusion-weighted echo-planar images. Magnetic Resonance in Medicine, 52, 1184–1189. Smith, S. M. et al. (2004). Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage, 23, S208–S219.
635
Vasconcelos, L. G., Brucki, S. M. D., Jackowiski, A. P. and Bueno, O. F. A. (2009). Diffusion tensor imaging for Alzheimer’s disease: a review of concepts and potential clinical applicability. Imagem do tensor de difusão na doença de Alzheimer: Revisão De Conceitos e Potenciais Aplicabilidades Clínicas, 3, 268–274. Walker, M. P. et al. (2000). Quantification and characterisation of fluctuating cognition in dementia with Lewy bodies and Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders, 11, 327–335. Watson, R. and O’Brien, J. T. (2012). Differentiating dementia with Lewy bodies and Alzheimer’s disease using MRI. Neurodegenerative Disease Management, 2, 1– 10. Watson, R. et al. (2012a). Characterizing dementia with Lewy bodies by means of diffusion tensor imaging. Neurology, 79, 906–914. Watson, R., O’Brien, J. T., Barber, R. and Blamire, A. M. (2012b). Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study. International Psychogeriatrics, 24, 532–540. Whitwell, J. L. et al. (2007). Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer’s disease. Brain, 130, 708–719. Yushkevich, P. A. et al. (2006). User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage, 31, 1116–1128.
